Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05833334 · ClinicalTrials.gov registry record · NA

Healthy Homes Study

A NA study of Lung Cancer and Home Air Radon Testing, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
172
Enrollment target
1
Study location

NCT05833334 is a NA study of Lung Cancer and Home Air Radon Testing that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 172 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05833334, a NA study of Lung Cancer and Home Air Radon Testing, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
172 participants
Enrollment target
1
Study location

Study Summary

This study is about home air radon testing and has two phases. The goal of the first phase is to learn about renters' and homeowners' views and plans related to radon testing. The main question this phase aims to answer is: 1\. Does taking part in a focus group with information about radon testing change people's plans to test for radon? Participants in the first study phase will: * Take a survey about their views on and plans for radon testing. * Take part in a focus group discussion about radon testing, during which they will receive information about radon testing. * Right after the focus group, take a survey about their plans for radon testing. The second phase is a pilot interventional study. The goal is to test interventions about radon testing with renters and homeowners who smoke and do not smoke. The main questions this phase aims to answer are: 1. Does the recruitment strategy result in enough participants enrolling within 3 months? 2. Will at least 80% of participants complete data collection activities? 3. Will more participants who view an online intervention developed by the researchers request free radon test kits, set them up in their homes, and complete radon testing, compared to participants who view a standard public health infographic? And will even more participants who receive reminder messages, in addition to the online intervention, request free radon test kits, set them up in their homes, and complete radon testing? Participants in this second phase will: * Take a survey about their views on and plans for radon testing. * View an intervention about radon testing. * Right after viewing the intervention, take a survey about their views on and plans for radon testing. * 2 months later, take a survey about what, if any, steps they've taken to test their homes for radon. * Provide the researchers permission to collect data from their State Radon Program on: a) whether they requested a free radon test kit and b) whether testing was complet

Interventions

  • BEHAVIORAL Public health infographic (AIM 3)
  • BEHAVIORAL Online health promotion intervention tailored by smoking status (AIM 3)
  • BEHAVIORAL Online health promotion intervention tailored by smoking status, plus reminder messages (AIM 3)
  • BEHAVIORAL Focus group with educational overview (AIM 1)

Study Locations (1)

New Hampshire

  • Dartmouth Cancer Center - Lebanon

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2023-06-01
Est. Completion 2027-08-24
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT05833334

The ClinicalTrials.gov registry entry for NCT05833334 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (82% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Public health infographic (AIM 3) is the first listed.

NCT05833334 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05833334 about?

NCT05833334 is a clinical study titled "Healthy Homes Study". This study is about home air radon testing and has two phases. The goal of the first phase is to learn about renters' and homeowners' views and plans related to radon testing. The main question this phase aims to answer is: 1\. Does taking part in a focus group with information about radon testing...

What is the current status of trial NCT05833334?

This trial is currently recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2023-06-01. Estimated completion is 2027-08-24.

What conditions does trial NCT05833334 study?

This clinical trial studies the following conditions: Lung Cancer, Home Air Radon Testing.

What interventions are being tested in trial NCT05833334?

The interventions under investigation include: Public health infographic (AIM 3) (BEHAVIORAL), Online health promotion intervention tailored by smoking status (AIM 3) (BEHAVIORAL), Online health promotion intervention tailored by smoking status, plus reminder messages (AIM 3) (BEHAVIORAL), Focus group with educational overview (AIM 1) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05833334?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05833334 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.